cS5F promotes the growth of hematopoietic progenitor cells
| cS5F-BM* . | Thy1.2 . | CD19 . | Mac-1 . | Gr-1 . | Ter119 . | CD117 . | CD34 . | Sca-1 . |
|---|---|---|---|---|---|---|---|---|
| Day 0 | 9.5 ± 1 | 12.25 ± 5.5 | 44.5 ± 8.4 | 44.25 ± 8.8 | 15.5 ± 1.9 | 15.75 ± 1.7 | 5.5 ± 1.3 | 9.25 ± 0.96 |
| Day 7 | 0.375 ± 0.03 | 2.45 ± 0.07 | 0.9 ± 0.8 | 6.3 ± 1 | 5.9 ± 0.7 | 99.25 ± 0.7 | 43.6 ± 7.39 | 56.8 ± 4.1 |
| cS5F-BM* . | Thy1.2 . | CD19 . | Mac-1 . | Gr-1 . | Ter119 . | CD117 . | CD34 . | Sca-1 . |
|---|---|---|---|---|---|---|---|---|
| Day 0 | 9.5 ± 1 | 12.25 ± 5.5 | 44.5 ± 8.4 | 44.25 ± 8.8 | 15.5 ± 1.9 | 15.75 ± 1.7 | 5.5 ± 1.3 | 9.25 ± 0.96 |
| Day 7 | 0.375 ± 0.03 | 2.45 ± 0.07 | 0.9 ± 0.8 | 6.3 ± 1 | 5.9 ± 0.7 | 99.25 ± 0.7 | 43.6 ± 7.39 | 56.8 ± 4.1 |
Bone marrow cells from cS5F leukemic mice (n = 4) were subjected to FACS analysis using indicated markers before (day 0) and after 1 week (day 7) of culture in medium containing SCF (10 ng/mL). Results are expressed as the percentage of positive cell markers among GFP-positive cells (mean ± SD).
n = 4.